Ventrixyl™ is indicated to provide vitamin supplements to men and women. Folic acid is effective in the treatment of megaloblastic anemias due to a deficiency of folic acid (as may be seen in tropical or nontropical sprue) and in anemias of nutritional origin, pregnancy, infancy, or childhood.
One (1) Ventrixy™ caplet daily, between meals or as directed by a physician. Do not administer to children under the age of 12.
Do not use if bottle seal is broken. KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN. Store at controlled room temperature 20° to 25°C (68° to 77°F). [See USP]. Protect from light and moisture and avoid excessive heat. To report a serious adverse event or to obtain product information, contact 877-921-7873.
www.fda.gov/medwatchEach caplet contains:
Vitamin A (as retinyl acetate)……………….. 1500 mcg (5000 IU)
Vitamin C (as ascorbic acid)……………….……………… 120 mg
Vitamin D3 (as cholecalciferol)…………….……. 20 mcg (800 IU)
Vitamin E (dl-alpha tocopheryl acetate)……………. 30 mg (30IU)
Thiamin (as thiamine mononitrate)…………...……………… 3 mg
Riboflavin (vitamin B2)…………………………...…………. 3.4 mg
Niacin (as niacinamide)…………………………....………… 20 mg
Vitamin B6 (as pyridoxine hydrochloride)………….………. 20 mg
Folate (as folic acid)……….. 1700 mcg DFE (1000 mcg folic acid)
Vitamin B12 (as cyanocobalamin)………………….……….. 8 mcg
Calcium (as calcium carbonate)……………………...……. 200 mg
Magnesium (as magnesium oxide)……………………...… 200 mg
Zinc (as zinc oxide)………………………………………....... 25 mg
Selenium (as selenium amino acid chelate)……………….55 mcg
Manganese (as manganese sulfate)………………………. 2.3 mg
Chromium (as chromium polynicotinate)………………..... 35 mcg
Molybdenum (as molybdenum amino acid chelate)……... 45 mcg
Other Ingredients:
Organic cocoa powder, croscarmellose sodium, crospovidone, magnesium stearate, microcrystalline cellulose, silicon dioxide, stearic acid. Clear coating: (hydroxypropyl methylcellulose, PEG-8).
Ventrixyl™ is indicated to provide vitamin supplements to men and women. Folic acid is effective in the treatment of megaloblastic anemias due to a deficiency of folic acid (as may be seen in tropical or nontropical sprue) and in anemias of nutritional origin, pregnancy, infancy, or childhood.
This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.
Administration of folic acid alone is improper therapy for pernicious anemia and other megaloblastic anemias in which vitamin B 12 is deficient.
Folic acid in doses above 0.1 mg daily may obscure pernicious anemia, in that hematologic remission can occur while neurological manifestations remain progressive.
There is a potential danger in administering folic acid to patients with undiagnosed anemia, since folic acid may obscure the diagnosis of pernicious anemia by alleviating the hematologic manifestations of the disease while allowing the neurologic complications to progress. This may result in severe nervous system damage before the correct diagnosis is made. Adequate doses of vitamin B
12 may prevent, halt, or improve the neurologic changes caused by pernicious anemia.
The patient’s medical conditions and consumption of other drugs, herbs, and/or supplements should be considered.
For use on the order of a healthcare practitioner.
Call your doctor about side effects. To report side effects, call
PureTek Corporation at
1-877-921-7873 or FDA at 1-800-FDA-1088 or
www.fda.gov/medwatch
Ventrixyl™ is not recommended for and should not be given to patients receiving levodopa because the action of levodopa is antagonized by pyridoxine. There is a possibility of increased bleeding due to pyridoxine interaction with anticoagulants (e.g., Aspirin, Heparin, or Clopidogrel).
Allergic sensitization has been reported following both oral and parenteral administration of folic acid.
Adverse reactions have been reported with specific vitamins and minerals but generally at levels substantially higher than those contained herein. However, allergic and idiosyncratic reactions are possible at lower levels. Iron, even at the usual recommended levels, has been associated with gastrointestinal intolerance in some patients.
One (1) Ventrixy™ caplet daily, between meals or as directed by a physician. Do not administer to children under the age of 12.
Ventrixyl™ are beige speckled, oblong, coated caplets in bottles containing 30 caplets – NDC 59088-186-54. Dispense in a tight, light-resistant container as defined in the USP/NF with a child-resistant closure. Store at controlled room temperature 20° to 25°C (68° to 77°F). [See USP]. Protect from light and moisture and avoid excessive heat.
Do not use if bottle seal is broken.
KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN.
Store at controlled room temperature 20° to 25°C (68° to 77°F). [See USP].
Protect from light and moisture and avoid excessive heat.
To report a serious adverse event or to obtain product information, contact
877-921-7873.
Manufactured in the USA by:
PureTek Corporation
Panorama City, CA 91402
Questions? Call toll-free:
1-877-921-7873
List No: 18654IAA Rev: 38311
| Class | Version | Type | Effective |
|---|---|---|---|
| ASCORBIC ACID Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| CALCIUM CATION Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20230427 |
| CHOLECALCIFEROL Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| CYANOCOBALAMIN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| MAGNESIUM CATION Pharmacologic Class Indexing | 4 | Indexing - Pharmacologic Class | 20180813 |
| MANGANESE CATION (2+) Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| PYRIDOXINE Pharmacologic Class Indexing | 1 | Indexing - Pharmacologic Class | 20170310 |
| VITAMIN A Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| ZINC CATION Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 59088-186-54 | Ventrixyl | 30 in 1 BOTTLE, PLASTIC | TABLET | 30 | 5 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 59088-186-54 | EA - Each | 59088-186 | a920ac3b-5e64-486c-930d-74a9bb11bb14 | 1 | 2021-07-15 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 59088-186 | 59088-186-54 |
Every source-derived ingredient row is available through these pages.
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ventrixyl | FOLIC ACID | PureTek Corporation | c29dc729-93be-2a20-e053-2a95a90a8ca3 | 2024-12-03 | Warnings, Adverse reactions | 59088-186-54 59088-186 59088018654 286669b9-5e8e-a446-e063-6394a90a2287 c29dc729-93be-2a20-e053-2a95a90a8ca3 |
Adverse event summaries are temporarily unavailable. Other product information remains available.